v3.21.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Operating Expenses:    
Research and development expenses $ 2,051,623 $ 1,059,578
General and administrative expenses 2,788,711 1,240,667
Total Operating Expenses 4,840,334 2,300,245
Loss From Operations (4,840,334) (2,300,245)
Other Income (Expense)    
Gain on change in value of contingent liability 6,275
Interest income 295 23,432
Total Other Income (Expense) 6,570 23,432
Loss Before Provision For Income Taxes (4,833,764) (2,276,813)
Benefit from income taxes
Net Loss $ (4,833,764) $ (2,276,813)
Net loss per share, basic and diluted (in Dollars per share) $ (0.30) $ (0.22)
Weighted average shares, basic and diluted (in Shares) 15,911,897 10,497,325

Source